BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20132214)

  • 21. DNA ploidy patterns in advanced gastric carcinoma; is it a clinically applicable prognosticator?
    Lee JH; Noh SH; Lee KY; Choi SH; Min JS
    Hepatogastroenterology; 2001; 48(42):1793-6. PubMed ID: 11813626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of DNA ploidy pattern and overexpression of p53 protein in cases of early gastric carcinoma with lymph node metastasis].
    Kido K; Sasaki O; Nagahama S; Yamashita Y; Baba M; Tashiro K; Kume T; Shirakusa T
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():320-3. PubMed ID: 9263523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study on prognostic significance of DNA ploidy and Ki-67 expression in colorectal cancer.
    Santagostino A; Saggia C; Migliora P; Pavanelli MC; Forti G; Biaggi G; Angeli G; Dacorsi M; Alabiso O
    J Biol Regul Homeost Agents; 2007; 21(1-2):13-20. PubMed ID: 18211746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
    Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma.
    Liu AW; Cai J; Zhao XL; Xu AM; Fu HQ; Nian H; Zhang SH
    J Clin Pathol; 2009 Nov; 62(11):1003-8. PubMed ID: 19861558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric DNA analysis of gastric cancer that is invading the muscularis propria.
    Mizunuma H; Tsuchiya A; Ando Y; Kikuchi Y; Abe R
    Eur J Surg; 1996 Nov; 162(11):889-94. PubMed ID: 8956958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of low expression of Prostasin mRNA in human gastric cancer.
    Sakashita K; Mimori K; Tanaka F; Tahara K; Inoue H; Sawada T; Ohira M; Hirakawa K; Mori M
    J Surg Oncol; 2008 Dec; 98(7):559-64. PubMed ID: 18932242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
    Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
    Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA ploidy heterogeneity in early and advanced gastric cancers.
    Fujimaki E; Sasaki K; Nakano O; Chiba S; Tazawa H; Yamashiki H; Orii S; Sugai T
    Cytometry; 1996 Jun; 26(2):131-6. PubMed ID: 8817089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between endoscopy, histopathology, and DNA flow cytometry in patients with gastric dyspepsia.
    Abdel-Wahab M; Attallah AM; Elshal MF; Eldousoky I; Zalata KR; el-Ghawalby NA; Gad el-Hak N; el-Ebidy G; Ezzat F
    Hepatogastroenterology; 1996; 43(11):1313-20. PubMed ID: 8908567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients.
    Li W; Yu CP; Xia JT; Zhang L; Weng GX; Zheng HQ; Kong QL; Hu LJ; Zeng MS; Zeng YX; Li M; Li J; Song LB
    Clin Cancer Res; 2009 Feb; 15(4):1393-9. PubMed ID: 19228740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
    Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
    Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of c-erbB-2 and DNA ploidy patterns in gastric carcinoma recurrence.
    Noguchi Y; Tsuburaya A; Makino T; Fukuzawa K; Nomura K; Yoshikawa T; Imada T; Amano T; Matsumoto A
    Int Surg; 1993; 78(2):107-11. PubMed ID: 8102619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
    Yamamoto H; Horiuchi S; Adachi Y; Taniguchi H; Nosho K; Min Y; Imai K
    Carcinogenesis; 2004 Mar; 25(3):325-32. PubMed ID: 14604892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
    Yang YH; Deng H; Li WM; Zhang QY; Hu XT; Xiao B; Zhu HH; Geng PL; Lu YY
    Clin Cancer Res; 2008 Jan; 14(1):74-81. PubMed ID: 18172255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrations of BUBR1 and TP53 gene mutually associated with chromosomal instability in human colorectal cancer.
    Zhao Y; Ando K; Oki E; Ikawa-Yoshida A; Ida S; Kimura Y; Saeki H; Kitao H; Morita M; Maehara Y
    Anticancer Res; 2014 Oct; 34(10):5421-7. PubMed ID: 25275037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BubR1 and AURKB overexpression are associated with a favorable prognosis in gastric cancer.
    Enjoji M; Iida S; Sugita H; Ishikawa T; Uetake H; Inokuchi M; Yamada H; Kojima K; Sugihara K
    Mol Med Rep; 2009; 2(4):589-96. PubMed ID: 21475871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.